Modeling different infectious phases of hepatitis B with generalized saturated incidence: An analysis and control

Tahir Khan1, Fathalla A Rihan1, Muhammad Ibrahim2

  • 1Department of Mathematical Sciences, UAE University, P.O.Box 15551, Al-Ain, United Arab Emirates.

Insights

This study models Hepatitis B virus (HBV) infection dynamics using a generalized saturated incidence rate. The model aids in understanding disease progression and developing control strategies to reduce HBV prevalence.

Area of Science:

  • Epidemiology
  • Mathematical Biology
  • Virology

Background:

  • Hepatitis B virus (HBV) infection is a major global health concern, causing significant mortality and morbidity.
  • Approximately 250 million people worldwide suffer from chronic Hepatitis B, a condition linked to liver damage and cancer.
  • Existing models may oversimplify HBV's complex infection phases, necessitating more sophisticated approaches.

Purpose of the Study:

  • To develop and analyze a mathematical model for Hepatitis B infection dynamics.
  • To incorporate multiple infection phases using a generalized saturated incidence rate.
  • To explore potential control strategies for mitigating HBV spread and impact.

Main Methods:

  • Construction of a mathematical model for HBV infection dynamics.
  • Analysis of model well-posedness, reproduction number, and equilibria.
  • Investigation of model stability conditions and control strategies.
  • Numerical simulations to validate biological significance and control implementation.

Main Results:

  • The proposed model was demonstrated to be well-posed.
  • Analysis provided insights into the time dynamics and stability of HBV infection.
  • The study identified potential control mechanisms to manage HBV infection rates.

Conclusions:

  • A generalized saturated incidence rate model effectively captures the complex dynamics of Hepatitis B infection phases.
  • The model serves as a valuable tool for understanding HBV epidemiology and evaluating control interventions.
  • Further research can refine control strategies for more effective HBV prevention and management.